Individually tailored screening of susceptibility to sarcopenia using p53 codon 72 polymorphism, phenotypes, and conventional risk factors

scientific article

Individually tailored screening of susceptibility to sarcopenia using p53 codon 72 polymorphism, phenotypes, and conventional risk factors is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1155/2014/743634
P932PMC publication ID4211310
P698PubMed publication ID25371596
P5875ResearchGate publication ID267263767

P50authorFrancesca SarloQ56926253
Andrea CabibboQ85911649
Antonino De LorenzoQ85911651
P2093author name stringLaura Di Renzo
Carmen Colica
Santo Gratteri
P2860cites workTotal-body skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry methodQ74529698
Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesityQ85223826
Identification of the receptor component of the IkappaBalpha-ubiquitin ligaseQ22008569
Regional differences in cellular mechanisms of adipose tissue gain with overfeedingQ24624643
Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older PeopleQ24633789
Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicineQ27024626
Surfing the p53 networkQ28032484
Increased nuclear proteins in muscle satellite cells in aged animals as compared to young growing animalsQ28577528
Maximal extraction of biological information from genetic interaction dataQ28755007
Obesity: preventing and managing the global epidemic. Report of a WHO consultationQ29547404
p53 in health and diseaseQ29619939
p53 mutant mice that display early ageing-associated phenotypesQ29622826
SIRT1 undergoes alternative splicing in a novel auto-regulatory loop with p53.Q33727892
Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortalityQ33728251
Skeletal muscle loss: cachexia, sarcopenia, and inactivityQ34099406
Waist circumference and not body mass index explains obesity-related health riskQ34301193
Normal weight obese (NWO) women: an evaluation of a candidate new syndromeQ34584574
Normal-weight obese syndrome: early inflammation?Q34599163
Normal weight obesity is associated with metabolic syndrome and insulin resistance in young adults from a middle-income country.Q34654065
Increased Plin2 expression in human skeletal muscle is associated with sarcopenia and muscle weaknessQ34974245
Gene expression profiles resulting from stable loss of p53 mirrors its role in tissue differentiationQ35060929
Catabolism of aging: is it an inflammatory process?Q35104886
Predicting the influence of multiple components on microbial inhibition using a logistic response model--a novel approachQ35188026
Intramuscular adipose tissue, sarcopenia, and mobility function in older individualsQ35829783
AccII polymorphism of the p53 geneQ35872939
Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implicationsQ35926379
Codon 72 polymorphism (rs1042522) of TP53 is associated with changes in diastolic blood pressure over timeQ35969007
Molecular and cellular mechanisms of skeletal muscle atrophy: an update.Q36179105
Intracellular signaling during skeletal muscle atrophyQ36288224
Estimating the population attributable risk for multiple risk factors using case-control dataQ36499362
Association of body composition with sarcopenic obesity in elderly womenQ36558227
Women's higher health risks in the obesogenic environment: a gender nutrition approach to metabolic dimorphism with predictive, preventive, and personalised medicineQ36575768
The p53 Codon 72 Polymorphism Modifies the Cellular Response to Inflammatory Challenge in the LiverQ37120247
Obesity genes and gene-environment-behavior interactions: recommendations for a way forwardQ37244322
Subclinical vascular inflammation in subjects with normal weight obesity and its association with body fat: an 18 F-FDG-PET/CT study.Q37714570
Mechanisms of muscle wasting in sarcopenia.Q37998359
Role of the Crosstalk between Autophagy and Apoptosis in CancerQ38120523
The concept of normal weight obesityQ38179549
Oxidative stress in normal-weight obese syndrome.Q38345413
Body composition and -174G/C interleukin-6 promoter gene polymorphism: association with progression of insulin resistance in normal weight obese syndrome.Q38359230
Systems pharmacology meets predictive, preventive, personalized and participatory medicineQ39205321
Differential levels of transcription of p53-regulated genes by the arginine/proline polymorphism: p53 with arginine at codon 72 favors apoptosis.Q39761795
Subcutaneous adipocyte size and body fat distributionQ39827789
Systems biology and new technologies enable predictive and preventative medicine.Q40473946
Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.Q40767544
The role of wild-type p53 in the differentiation of primary hemopoietic and muscle cellsQ40922665
Defining the regulatory networks for muscle development.Q41099976
p53-independent expression of p21Cip1 in muscle and other terminally differentiating cellsQ41368682
A new predictive equation for evaluating women body fat percentage and obesity-related cardiovascular disease riskQ42231576
p53 regulates myogenesis by triggering the differentiation activity of pRb.Q42941221
Adiposity rather than BMI determines metabolic riskQ44438006
Prevalence of sarcopenia based on different diagnostic criteria using DEXA and appendicular skeletal muscle mass reference values in an Italian population aged 20 to 80.Q46890037
Prevalence of normal weight obesity in Switzerland: effect of various definitionsQ47226762
Interleukin-1 (IL-1) receptor antagonist gene polymorphism in normal weight obese syndrome: relationship to body composition and IL-1 alpha and beta plasma levels.Q47309657
Normal Weight Obese syndrome: role of single nucleotide polymorphism of IL-1 5Ralpha and MTHFR 677C-->T genes in the relationship between body composition and resting metabolic rate.Q47313129
Body composition analyses in normal weight obese women.Q47325574
Comparisons of waist circumferences measured at 4 sitesQ47614423
P275copyright licenseCreative Commons Attribution 3.0 UnportedQ14947546
P6216copyright statuscopyrightedQ50423863
P921main subjectsarcopeniaQ1787939
P304page(s)743634
P577publication date2014-10-13
P1433published inDisease MarkersQ15756044
P1476titleIndividually tailored screening of susceptibility to sarcopenia using p53 codon 72 polymorphism, phenotypes, and conventional risk factors
P478volume2014

Reverse relations

cites work (P2860)
Q47363867Association of body composition and eating behavior in the normal weight obese syndrome.
Q33785098Can psychobiotics intake modulate psychological profile and body composition of women affected by normal weight obese syndrome and obesity? A double blind randomized clinical trial
Q97884559From obesity through gut microbiota to cardiovascular diseases: a dangerous journey
Q26774656New obesity classification criteria as a tool for bariatric surgery indication
Q90060498Obesity subtypes, related biomarkers & heterogeneity
Q47725934Physical Activity and Nutrition INfluences In ageing (PANINI): consortium mission statement.
Q92636627Prevention and Treatment of Sarcopenic Obesity in Women
Q53193618Replication study of the vitamin D receptor (VDR) genotype association with skeletal muscle traits and sarcopenia.
Q53700576The influence of diet on anti-cancer immune responsiveness.
Q64275689Why primary obesity is a disease?